Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fresenius SE & Co. KGaA

http://www.fresenius.com

Latest From Fresenius SE & Co. KGaA

Certa Plans Pivotal Scleroderma Trial As GPCR Antagonist Hits Phase II Bullseye

Certa’s lead candidate has shown promise in a mid-stage trial for the rare but debilitating skin disorder, triggering pivotal development plans to address the high unmet need.

Clinical Trials Rare Diseases

Deals In 2023: Partnerships And Modest M&A

Mid-sized M&A, collaborations, creative financing, and biotech consolidation will feature in 2023. IPOs and follow-ons play bit-parts.

Growth Deals

Elicio Uses Reverse Merger With Angion To Go Public At Last

After withdrawing IPO plans last September, Elicio thinks merger with Angion will give it a cash runway through end of 2023 to advance ELI-002, a vaccine for mutant KRAS-driven solid tumors.

M & A Business Strategies

Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players

As the usual flurry of deals coincides with the J.P. Morgan Healthcare Conference, AbbVie signed an mRNA pact with Anima and a cancer research tie-up with Immunome.

Deal Watch Business Strategies
See All

Company Information

  • Industry
  • Distributors
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Services
  • Other Names / Subsidiaries
    • APP Pharmaceuticals, Inc.
    • Asia Renal Care Ltd.
    • Fresenius Kabi Pharmaceuticals Holding, Inc.
    • Fresenius Medical Care
    • Fresenius Medical Group AG
    • Vifor-Fresenius Medical Care Renal Pharma Ltd. (VFMCRP)
    • Xenios AG
UsernamePublicRestriction

Register